Effective treatments for PAH will require detailed knowledge of molecular aetiology

International Journal of Clinical Practice

Volumn 64, Issue SUPPL. 168, 2010, Pages 3-4

  Johnson, J ^a   Loyd, J ^a   West, J ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; STEROID; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT;

CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CYTOSKELETON; ENERGY METABOLISM; ESTROGEN METABOLISM; FAMILY; GASTROINTESTINAL TUMOR; GENE IDENTIFICATION; GENE MUTATION; HUMAN; INFLAMMATION; LUNG HEMORRHAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT SURVEY; STEROID THERAPY;

EID: 78649287618     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02526.x     Document Type: Short Survey

References (10)

1. Thenappan T, Shah SJ, Rich S, et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35: 1079 - 87.
2. Ghofrani HA, Seeger W, Grimminger F,. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005; 353: 1412 - 3.
3. Galie N, Boonstra A, Ewert R, et al. Effects of inhaled aviptadil (vasoactive intestinal peptide) in patients with pulmonary arterial hypertension (PAH). Am J Respir Crit Care Med 2010; 181: A2516.
4. Donn R, Berry A, Stevens A, et al. Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J 2007; 21: 402 - 14.
5. Machado RD, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 1 (Suppl.): S32 - 42.
6. Rajkumar R, Konishi K, Richards TJ, et al. Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol 2010; 298: H1235 - 48.
7. Wojciak-Stothard B, Tsang LY, Paleolog E, et al. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1173 - 82.
8. De Jesus Perez VA, Alastalo TP, Wu JC, et al. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol 2009; 184: 83 - 99.
9. Pugh M, Hemnes A, Robbins I, et al. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 181: A4813 [abstract].
10. Archer SL, Gomberg-Maitland M, Maitland ML, et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294: H570 - 8.